Literature DB >> 21266361

Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.

Keisuke Taniuchi1, Isao Nishimori, Michael A Hollingsworth.   

Abstract

We report a novel function for the CD24 molecule in pancreatic cancer cells. Intracellular CD24 is associated with stress granules that contain specific mRNAs and RNA-binding proteins that regulate mRNA stability and translation. Intracellular CD24 in stress granules is associated with G3BP, a phosphorylation-dependent endoribonuclease. The vesicles in which the CD24/G3BP complex localizes are transported toward cell protrusions in migrating cells. We show that G3BP binds to and degrades Binder of Arl Two (BART) mRNA. BART was originally identified as a binding partner of ARL2, a small G-protein implicated as a regulator of microtubule dynamics and folding. Intracellular CD24 inhibits the specific endoribonuclease activity of G3BP toward BART mRNA in stress granules. We show that knockdown of CD24 increases retroperitoneal invasion and liver metastasis of pancreatic cancer cells in an orthotopic xenograft model, and that BART also prevents retroperitoneal invasion and liver metastasis of pancreatic cancer cells. Our results imply that surface CD24 may play a role in the inhibition of cell invasion and metastasis, and that intracellular CD24 inhibits invasiveness and metastasis through its influence on the posttranscriptional regulation of BART mRNA levels via G3BP RNase activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266361     DOI: 10.1158/0008-5472.CAN-10-2743

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.

Authors:  Niko Bretz; Aurelia Noske; Sascha Keller; Natalie Erbe-Hofmann; Thomas Schlange; Alexei V Salnikov; Gerd Moldenhauer; Glen Kristiansen; Peter Altevogt
Journal:  Clin Exp Metastasis       Date:  2011-10-08       Impact factor: 5.150

2.  BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.

Authors:  Keisuke Taniuchi; Kunihiko Yokotani; Toshiji Saibara
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

3.  The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.

Authors:  Makiko Tsuboi; Keisuke Taniuchi; Takahiro Shimizu; Motoaki Saito; Toshiji Saibara
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.157

4.  CD24 controls Src/STAT3 activity in human tumors.

Authors:  Niko P Bretz; Alexei V Salnikov; Claudia Perne; Sascha Keller; Xiaoli Wang; Claudia T Mierke; Mina Fogel; Natalie Erbe-Hofmann; Thomas Schlange; Gerhard Moldenhauer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

5.  Cancer Stem Cells: An Ever-Hiding Foe.

Authors:  Jacek R Wilczyński
Journal:  Exp Suppl       Date:  2022

6.  UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.

Authors:  John Henry Owen; Christine M Komarck; Anthony C Wang; Waleed M Abuzeid; Richard F Keep; Erin L McKean; Stephen Sullivan; Xing Fan; Mark E P Prince
Journal:  J Neurosurg       Date:  2017-04-21       Impact factor: 5.115

7.  Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.

Authors:  Jason E Duex; Charles Owens; Ana Chauca-Diaz; Garrett M Dancik; Lauren A Vanderlinden; Debashis Ghosh; Mariah Z Leivo; Donna E Hansel; Dan Theodorescu
Journal:  Cancer Res       Date:  2017-07-03       Impact factor: 12.701

8.  BCL7B, a predictor of poor prognosis of pancreatic cancers, promotes cell motility and invasion by influencing CREB signaling.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Seiji Naganuma; Ken Dabanaka; Kazuhiro Hanazaki; Toshiji Saibara
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

9.  BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7.

Authors:  Keisuke Taniuchi; Kunihiko Yokotani; Toshiji Saibara
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

10.  Stress Granules in Cancer.

Authors:  Min-Seok Song; Elda Grabocka
Journal:  Rev Physiol Biochem Pharmacol       Date:  2020-08-14       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.